Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Price

Showing results (191-200 of 208) with videos related to

Pageof 21
Sort By:
Archives of Surgery (Chicago, Ill. : 1960)|May 1, 1996
Long-term results with the Kasai operation for biliary atresiaF M Karrer, M R Price, D D Bensard, et al.
International Journal of Cancer|July 15, 1982
In vivo localization of anti-osteogenic sarcoma 791T monoclonal antibody in osteogenic sarcoma xenograftsM V Pimm, M J Embleton, A C Perkins, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 5, 2001
Production and characterization of 188Re-C595 antibody for radioimmunotherapy of transitional cell bladder cancerA Murray, M S Simms, D P Scholfield, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1988
Potentiation of anti-carcinoembryonic antigen immunotoxin cytotoxicity by monoclonal antibodies reacting with co-expressed carcinoembryonic antigen epitopesV S Byers, I Pawluczyk, I Pawlucyzk, et al.
Journal of Clinical Immunology|November 1, 1993
Suppression of antibody responses to ricin A chain (RTA) by monoclonal anti-RTA antibodiesV S Byers, E B Austin, J A Clegg, et al.
Biospectroscopy|April 27, 1999
Structure/activity studies of the anti-MUC1 monoclonal antibody C595 and synthetic MUC1 mucin-core-related peptides and glycopeptidesD I Spencer, S Missailidis, G Denton, et al.
European Journal of Nuclear Medicine|April 1, 1997
Preclinical evaluation of copper-67 labelled anti-MUC1 mucin antibody C595 for therapeutic use in bladder cancerO D Hughes, M C Bishop, A C Perkins, et al.
Cancer Immunology, Immunotherapy : CII|May 11, 1999
Production and characterization of an anti-(MUC1 mucin) recombinant diabodyG Denton, K Brady, B K Lo, et al.
British Journal of Cancer|May 1, 1990
C595--a monoclonal antibody against the protein core of human urinary epithelial mucin commonly expressed in breast carcinomasM R Price, J A Pugh, F Hudecz, et al.
European Journal of Cancer & Clinical Oncology|August 1, 1987
Identification of a monoclonal antibody-defined breast carcinoma antigen in body fluidsM R Price, G Crocker, S Edwards, et al.
Pageof 21

Showing results (191-200 of 208) with videos related to

Sort By:
Pageof 21
Archives of Surgery (Chicago, Ill. : 1960)|May 1, 1996
Long-term results with the Kasai operation for biliary atresiaF M Karrer, M R Price, D D Bensard, et al.
International Journal of Cancer|July 15, 1982
In vivo localization of anti-osteogenic sarcoma 791T monoclonal antibody in osteogenic sarcoma xenograftsM V Pimm, M J Embleton, A C Perkins, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 5, 2001
Production and characterization of 188Re-C595 antibody for radioimmunotherapy of transitional cell bladder cancerA Murray, M S Simms, D P Scholfield, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1988
Potentiation of anti-carcinoembryonic antigen immunotoxin cytotoxicity by monoclonal antibodies reacting with co-expressed carcinoembryonic antigen epitopesV S Byers, I Pawluczyk, I Pawlucyzk, et al.
Journal of Clinical Immunology|November 1, 1993
Suppression of antibody responses to ricin A chain (RTA) by monoclonal anti-RTA antibodiesV S Byers, E B Austin, J A Clegg, et al.
Biospectroscopy|April 27, 1999
Structure/activity studies of the anti-MUC1 monoclonal antibody C595 and synthetic MUC1 mucin-core-related peptides and glycopeptidesD I Spencer, S Missailidis, G Denton, et al.
European Journal of Nuclear Medicine|April 1, 1997
Preclinical evaluation of copper-67 labelled anti-MUC1 mucin antibody C595 for therapeutic use in bladder cancerO D Hughes, M C Bishop, A C Perkins, et al.
Cancer Immunology, Immunotherapy : CII|May 11, 1999
Production and characterization of an anti-(MUC1 mucin) recombinant diabodyG Denton, K Brady, B K Lo, et al.
British Journal of Cancer|May 1, 1990
C595--a monoclonal antibody against the protein core of human urinary epithelial mucin commonly expressed in breast carcinomasM R Price, J A Pugh, F Hudecz, et al.
European Journal of Cancer & Clinical Oncology|August 1, 1987
Identification of a monoclonal antibody-defined breast carcinoma antigen in body fluidsM R Price, G Crocker, S Edwards, et al.
Pageof 21